[Characterizing the molecular cytogenetics in acute monocytic leukemia]

Area of Science:

• Hematology
• Molecular Genetics
• Oncology

Background:

• Acute monocytic leukemia (AML) is a heterogeneous disease.
• Understanding the molecular landscape of AML is crucial for prognostication and treatment.

Purpose of the Study:

• To molecularly characterize 81 patients with acute monocytic leukemia (AML).
• To identify common gene mutations and their correlation with clinical outcomes.

Main Methods:

• Fluorescence in situ hybridization (FISH) for MLL gene rearrangements.
• DNA-based PCR and Sanger sequencing for mutations in 17 genes.

Main Results:

• 67 out of 81 patients (over 80%) harbored at least one mutation.
• NPM1, FLT3-ITD, NRAS, and DNMT3A were among the most frequently mutated genes.
• Increased number of mutations correlated with lower complete remission (CR) rates, particularly in patients with normal cytogenetics.

Conclusions:

• The majority of AML patients exhibit genetic mutations.
• The interplay between MLL gene rearrangements and multiple mutations influences clinical phenotype and prognosis.
• The number of mutations is inversely related to CR rates within risk strata.